Evidence map›Paper›PMID 38444631›Full record

ArticleFrontiers in medicine2023

Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1).

Marigdalia K Ramirez-Fort, Casey K Gilman, Jacob S Alexander, Barbara Meier-Schiesser, Arjan Gower, Mojtaba Olyaie, Neel Vaidya, Kiarash Vahidi, Yuxin Li, Christopher S Lange and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marigdalia K Ramirez-FortBioFort, Guaynabo, Puerto Rico.
Casey K GilmanBioFort, Guaynabo, Puerto Rico.
Jacob S AlexanderBioFort, Guaynabo, Puerto Rico.
Barbara Meier-SchiesserUniversity Hospital Zürich, Zürich, Switzerland.
Arjan GowerUniversity of California at Los Angeles (UCLA) Health System, Los Angeles, CA, United States.
Mojtaba OlyaieVeterans Affairs (VA) Greater Los Angeles Healthcare System, Veterans Health Administration, United States Department of Veterans Affairs, Los Angeles, CA, United States.
Neel VaidyaVeterans Affairs (VA) Greater Los Angeles Healthcare System, Veterans Health Administration, United States Department of Veterans Affairs, Los Angeles, CA, United States.
Kiarash VahidiVeterans Affairs (VA) Greater Los Angeles Healthcare System, Veterans Health Administration, United States Department of Veterans Affairs, Los Angeles, CA, United States.
Yuxin LiVeterans Affairs (VA) Greater Los Angeles Healthcare System, Veterans Health Administration, United States Department of Veterans Affairs, Los Angeles, CA, United States.
Christopher S LangeBioFort, Guaynabo, Puerto Rico.
Migdalia FortBioFort, Guaynabo, Puerto Rico.
Corinne DeurdulianVeterans Affairs (VA) Greater Los Angeles Healthcare System, Veterans Health Administration, United States Department of Veterans Affairs, Los Angeles, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

disease-inclusive languagefolate hydrolase-1gender-inclusive languageprostate-specific membrane antigentheragnostic target

Identifiers

PMID38444631
PMCPMC10913592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.